Abvc Biopharma, Inc. (ABVC): Revenue

Annual figures by period end, from SEC filings.

$296.0K

Year ended 2025-12-31

-40.1%

10-year compound annual growth

2015-12-31 Revenue (USD) 2025-12-31

Period ended	Revenue	Change YoY	Source filing
2025-12-31	$296.0K	-41.9%	2026-03-03, From 2025-01-01
2024-12-31	$509.6K	n/a	2026-03-03, From 2024-01-01
No annual figure between 2015-12-31 and 2024-12-31.
2015-12-31	$50.00M	n/a	2025-04-15, From 2015-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Revenue	Change YoY
Abvc Biopharma, Inc. (ABVC)	2025-12-31	$296.0K	-41.9%
Vyome Holdings, Inc (HIND)	2025-12-31	$319.7K	+24.4%
Allarity Therapeutics, Inc. (ALLR)	2025-12-31	$320.0K	n/a
Provectus Biopharmaceuticals, Inc. (PVCT)	2025-12-31	$336.1K	-45.5%
Regen BioPharma Inc (RGBP)	2025-09-30	$236.6K	0.0%
America Great Health (AAGH)	2025-06-30	$391.7K	+32.9%
Can-Fite BioPharma Ltd. (CANF)	2025-12-31	$405.0K	-39.9%
Medicinova Inc (MNOV)	2025-12-31	$409.7K	n/a
Scienture Holdings, Inc. (SCNX)	2025-12-31	$431.6K	+215.9%

Compare ABVC, HIND, ALLR, PVCT side by side · Screen every company in Pharmaceutical Preparations ↗